Mapping of a novel MEN-like syndrome locus to rat Chromosome 4

Mammalian Genome

Volumn 15, Issue 2, 2004, Pages 135-141

  Piotrowska, Kamilla ^a   Pellegata, Natalia S ^a   Rosemann, Michael ^a   Fritz, Andreas ^a   Graw, Jochen ^a   Atkinson, Michael J ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 4; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; MALE; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA LIKE SYNDROME; NONHUMAN; PHENOTYPE; POINT MUTATION; PROTO ONCOGENE; RAT; RAT STRAIN; RECESSIVE INHERITANCE; SIPPLE SYNDROME;

ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; GENE ORDER; GENES, RECESSIVE; LOD SCORE; MICROSATELLITE REPEATS; MULTIPLE ENDOCRINE NEOPLASIA; RADIATION HYBRID MAPPING; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RODENT DISEASES;

ANIMALIA; ZOSTEROPIDAE;

EID: 0742324929     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-003-3027-8     Document Type: Article

References (27)

1. Alberti L, Carniti C, Miranda C, Roccato E, Pierotti MA (2003) RET and NTRK1 proto-oncogenes in human diseases. J Cell Physiol 195, 168-186
2. Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, et al. (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357, 1181-1182
3. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848-851
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404-407
5. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, et al. (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98, 1118-1123
6. Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TW, Wheeler DC, et al. (1995) Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. J Med Genet 32, 885-886
7. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, et al. (1993) Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 12, 851-856
8. Farrell WE, Clayton RN (2000) Molecular pathogenesis of pituitary tumors. Front Neuroendocrinol 21, 174-198
9. Fritz A, Walch A, Piotrowska K, Rosemann M, Schäffer E, et al. (2002) Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Res 62, 3048-3051
10. Hansford JR, Mulligan LM (2000) Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 37, 817-827
11. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, et al. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367, 375-376
12. Iwamoto T, Taniguchi M, Asai N, Ohkusu K, Nakashima I, et al. (1993) cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily. Oncogene 8, 1087-1091
13. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, et al. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340, 692-696
14. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249, 655-659
15. Maher ER, Eng C (2002) The pressure rises: update on the genetics of phaeochromocytoma. Hum Mol Genet 11, 2347-2354
16. Manly KF, Olson JM (1999) Overview of QTL mapping software and introduction to map manager QT. Mamm Genome 10, 327-334
17. Manly KF, Cudmore Jr RH, Meer JM (2001) Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome 12, 930-932
18. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458-460
19. Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JB, et al. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 6, 70-74
20. Murray AB, Schaffer E, Nussel M, Luz A (1985) Incidence, morphology, and ultrastructure of spontaneous thymoma - the most common neoplasm in W/Nhg rats. J Natl Cancer Inst. 75, 369-379
21. Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26, 268-270
22. Poisson A, Zablewska B, Gaudray P (2003) Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Lett 189, 1-10
23. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G (2002) Molecular mechanisms of RET activation in human cancer. Ann N Y Acad Sci 963, 116-121
24. Schneider R (1992) The human protooncogene ret: a communicative cadherin? Trends Biochem Sci 17, 468-469
25. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, et al. (1988) Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3, 571-578
26. Woodward ER, Eng C, McMahon R, Voutilainen R, Affara NA, et al. (1997) Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hum Mol Genet 6, 1051-1056
27. Zarnegar R, Brunaud L, Clark OH (2002) Multiple endocrine neoplasia type I. Curr Treat Options Oncol 3, 335-348